Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

CorMedix Inc. CRMD

Set alert

Price alert · CRMD

All alert types
5.39 USD -0.31 -5.36%

At close

5.40 +0.01 +0.18%

Pre-market · Nov 3, 8:19 AM ET

Bid
5.38 × 2
Ask
5.39 × 2
5.34 Day range 5.75
5.34 52-week range 13.02
YTD
-53.65%
1 year
-53.29%
Open
5.70
Prev close
5.70
Mkt cap
420.12M
Vol
3.30M
Avg vol
1.27M
EPS
2.05
P/E
2.63
Div yield
0.00%
More statistics
Low
5.34
High
5.75
Forward P/E
17.54
Beta
1.58
Short ratio
5.12
Inst. own
31.92%
Dividend
0.00
Ex-div date
50-d avg
10.35
200-d avg
6.57
1y target
16.25

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 6, 2025Earnings: 0.3; estimate 0.25; surprise 20%
  • Aug 7, 2025Earnings: 0.28; estimate 0.2; surprise 40%
Signals (73)
NameDateAgo
SMA: BearishJun 1, 20265 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BearishFeb 1, 20269 months ago
SMA: BearishJan 1, 202610 months ago
MACD: Sell SignalJan 1, 202610 months ago
SMA: BullishDec 1, 202511 months ago
SMA: BearishNov 1, 20251 year ago
SMA: BullishApr 1, 20251 year ago
SMA: BearishMar 1, 20251 year ago
RSI: OverboughtOct 1, 20242 years ago
SMA: BullishMar 1, 20242 years ago
SMA: BullishMar 1, 20242 years ago
MACD: Buy SignalMar 1, 20242 years ago
MACD: Sell SignalJan 1, 20242 years ago
SMA: BearishAug 1, 20233 years ago
SMA: BullishJul 1, 20233 years ago
SMA: BearishJun 1, 20233 years ago
MACD: Buy SignalJan 1, 20233 years ago
SMA: BullishNov 1, 20224 years ago
SMA: BearishAug 1, 20224 years ago

Newest 20 of 73.

Analyst view

Consensus: none

Price target (mean) 16.25 +201.5% upside
Target (low)
11.00
Target (mean)
16.25
Target (high)
19.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CRMD analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.050.03 – 0.06-0.26+119.2%19.97M0.0%4
Next quarter0.150.15 – 0.15-0.25+160.0%31.02M0.0%1
Current year-0.4975-0.54 – -0.45-0.91+45.3%32.25M0.0%4
Next year0.57750.24 – 0.94-0.4975+216.1%113.29M+251.3%4

Upgrades and downgrades

The latest rating changes

CRMD analyst upgrades and downgrades
DateFirmActionFromTo
Dec 19, 2024RBC CapitalMaintainedOutperformOutperform
Oct 31, 2024NeedhamMaintainedBuyBuy
Aug 15, 2024RBC CapitalReiteratedOutperformOutperform
Aug 15, 2024NeedhamReiteratedBuyBuy
Jul 25, 2024Truist SecuritiesMaintainedBuyBuy
Jun 19, 2024NeedhamReiteratedBuyBuy
May 13, 2024NeedhamReiteratedBuyBuy
Apr 9, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Apr 9, 2024NeedhamReiteratedBuyBuy
Mar 13, 2024RBC CapitalMaintainedOutperformOutperform
Mar 12, 2024NeedhamMaintainedBuyBuy
Jan 31, 2024Truist SecuritiesMaintainedBuyBuy
Nov 15, 2023NeedhamMaintainedBuyBuy
Nov 15, 2023RBC CapitalMaintainedOutperformOutperform
Nov 15, 2023Truist SecuritiesReiteratedBuyBuy
Nov 15, 2023JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Aug 10, 2023RBC CapitalInitiated—Outperform
Aug 8, 2023NeedhamMaintainedBuyBuy
Jun 21, 2023NeedhamReiteratedBuyBuy
May 19, 2023JMP SecuritiesMaintainedMarket OutperformMarket Outperform
May 16, 2023NeedhamReiteratedBuyBuy
Mar 31, 2023JMP SecuritiesReiterated—Market Outperform
Mar 31, 2023NeedhamReiterated—Buy
Mar 3, 2023NeedhamReiterated—Buy
Mar 1, 2023JMP SecuritiesMaintained—Market Perform
Nov 11, 2022NeedhamMaintained—Buy
Aug 12, 2022Truist SecuritiesMaintained—Buy
Aug 9, 2022JMP SecuritiesMaintained—Market Outperform
Aug 9, 2022NeedhamMaintained—Buy
May 14, 2021NeedhamMaintained—Buy